| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.068 | 0.1 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.1 |